1. Home
  2. JOE vs SYRE Comparison

JOE vs SYRE Comparison

Compare JOE & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo St. Joe Company (The)

JOE

St. Joe Company (The)

HOLD

Current Price

$67.20

Market Cap

3.7B

Sector

Real Estate

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$51.91

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOE
SYRE
Founded
1936
2013
Country
United States
United States
Employees
N/A
102
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
JOE
SYRE
Price
$67.20
$51.91
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$60.13
AVG Volume (30 Days)
222.2K
730.9K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
0.94%
N/A
EPS Growth
56.69
N/A
EPS
1.99
N/A
Revenue
$513,246,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.13
N/A
Revenue Growth
27.44
N/A
52 Week Low
$40.46
$12.04
52 Week High
$73.54
$54.39

Technical Indicators

Market Signals
Indicator
JOE
SYRE
Relative Strength Index (RSI) 53.71 67.75
Support Level $66.26 $39.64
Resistance Level $72.67 N/A
Average True Range (ATR) 1.73 2.77
MACD 0.56 0.41
Stochastic Oscillator 83.71 80.42

Price Performance

Historical Comparison
JOE
SYRE

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: